Starpharma Holdings Limited (SPL.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.7050 |
| Open | 0.7000 |
| Bid | 0.6950 x 334700 |
| Ask | 0.7100 x 1317400 |
| Day's range | 0.6950 - 0.7150 |
| 52-week range | 0.6200 - 1.4950 |
| Volume | |
| Avg. volume | 362,176 |
| Market cap | 283.868M |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 1988 |
| 1y target est | N/A |
- PR Newswire
Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 variant
In a major development for its VIRALEZE™ antiviral nasal spray, Starpharma (ASX: SPL) today announced that its potent antiviral agent, SPL7013, achieved the maximum possible virucidal effect against the highly transmissible Omicron variant of SARS-CoV-2.
- PR Newswire
Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam
Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in Vietnam, with a minimum commitment of 1 million units in the first year.
- PR Newswire
VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week
Australian biotech company Starpharma today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale in Vietnam, with the product scheduled to launch in Vietnam this week.
© 2022 Yahoo. All rights reserved.
